Home / Markets / Industries / Health Care
- Business Leaders
- Commodities
- Economy
- Market Overview
- Mutual Funds & ETFs
- Industries
- Innovation
- America's Road to Recovery
- America's Infrastructure
-
Friday, November 20, 2009
A European advisory committee has recommended approval for Merck & Co.'s (MRK) new fertility drug Elonva.
-
Friday, November 20, 2009
-
Friday, November 20, 2009
-
Friday, November 20, 2009
-
Thursday, November 19, 2009
China Medical Technologies Inc. (CMED) shares fell Thursday after the company posted a quarterly loss.
More News
Press Releases
- Glancy Binkow & Goldberg LLP Appointed Co-Lead Counsel In Skilled Healthcare Group, Inc. Securities Class Action
- Escalon(R) Reports First Quarter Fiscal 2010 Results
- U.S. Court of Appeals Upholds AstraZeneca AWP Settlement
- U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Treatment of Irritability Associated with Autistic Disorder in Pediatric Patients (Ages 6 to 17 Years)
- Importance of Real-Time CPR Feedback Presented at AHA Scientific Sessions 2009
- NUCRYST Announces Special Meeting of Shareholders
- NUCRYST Announces Special Meeting of Shareholders
- The Brualdi Law Firm, P.C. Announces Class Action Lawsuit Against Hemispherx Biopharma, Inc.
- iCo Therapeutics Completes Final Tranche of $4,000,000 Brokered Private Placement
- Zacks Analyst Blog Highlights: Aetna Inc., UnitedHealth Group Inc., WellPoint Inc., Assurant Inc. and Cigna Corp
